greeksoup/ stock research

Exponent (EXPO) FY2014 results: revenue $305 million, up 2.9% on the year

Exponent Inc. (EXPO) reported revenue of $305 million for fiscal 2014, the year ended 2 January 2015, up 2.9% on the year before. Net income was $41 million, up 5.3%, and diluted earnings per share $0.73. The figures are the company's own, from the 10-K it filed with the SEC on 2 March 2015.

Revenue
$305 million
+2.9% on the year
FY2009FY2014
Operating margin
20.9%
18.9% a year earlier
FY2009FY2014
Net income
$41 million
+5.3% on the year
FY2009FY2014
Diluted EPS
$0.73
+6.5% on the year
FY2009FY2014

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2014FY2013FY2012On the yearLast 8 years
Revenue305296293+2.9%
Operating income63.555.957.6+13.6%
Operating margin20.9%18.9%19.7%
Pre-tax income68.063.961.7+6.3%
Income tax27.325.324.5+7.7%
Effective tax rate40.1%39.6%39.7%
Net income40.738.637.2+5.3%
Net margin13.4%13.0%12.7%
Diluted EPS$0.73$0.69$0.65+6.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2014FY2013FY2012On the yearLast 8 years
Operating cash flow48.361.848.5-21.9%
Capital expenditure4.96.24.9-20.5%
Free cash flow43.355.643.6-22.1%
Free cash flow margin14.2%18.8%14.9%
Cash from investingn/an/a-1.2
Cash from financingn/an/a-18.9
Depreciation and amortisation5.45.04.7+9.1%
Share-based compensation13.113.212.4-0.7%
Buybacks30.925.522.9+21.2%
Dividends paid13.07.90.0+65.2%
Dividend per share$0.25$0.15$0.00+66.7%
Diluted shares, weighted55m56m57m-1.4%

Balance sheet

$ millionFY2014FY2013FY2012On the yearLast 8 years
Shareholders' equity244235216+3.9%
Debt0.00.00.0
Other liabilities12110999.0+10.9%
Total liabilities and equity365344315+6.1%
Fixed assets28.328.727.4-1.6%
Goodwill8.68.68.60.0%
Investments24.933.220.9-24.9%
Cash and equivalents129123113+5.3%
Receivables86.477.085.4+12.2%
Other assets87.773.759.9+18.9%
Total assets365344315+6.1%

10-K for the year ended 2 January 2015, filed 2 March 2015: the filing.